These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 13913913)

  • 21. [Sabin's oral vaccine with living virus against polio in Czechoslovakia. Its effectiveness in world-wide use in 1960].
    SKOVRANE V; ZACEK DE PRAGA K
    Rev Cubana Pediatr; 1962; 24():75-8. PubMed ID: 13913703
    [No Abstract]   [Full Text] [Related]  

  • 22. [Incidence of cytopathogenic enteric viruses in Lombardy 5 years after the introduction of antipoliomyelitic vaccination with the Sabin vaccine].
    Galli MG
    Ann Sclavo; 1971; 13(3):362-9. PubMed ID: 4340984
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative characteristics of live vaccine against poliomyelitis prepared in the Institute of Poliomyelitis Research of the AMN SSSR, and Sabin's vaccine from attenuated strains of the poliomyelitis virus].
    CHUMAKOV MP; GAGARINA AV; LASHKEVICH VA; DZAGUROZ SG; RAL'F NM; FLEER GP; VOROSHILOVA MK; ROBINZON Ia
    Vopr Virusol; 1959; 4():533-7. PubMed ID: 13810206
    [No Abstract]   [Full Text] [Related]  

  • 24. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine.
    JUNGHERR EL; CABASSO VJ; MOYER AW; COX HR
    J Infect Dis; 1961; 108():247-61. PubMed ID: 13791071
    [No Abstract]   [Full Text] [Related]  

  • 25. Developments in the production and quality control of poliovirus vaccines -- historical perspectives.
    Furesz J
    Biologicals; 2006 Jun; 34(2):87-90. PubMed ID: 16621594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J; Contreras G
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MASS IMMUNISATION AGAINST POLIOMYELITIS IN CEYLON IN 1962 USING SABIN ORAL VACCINE.
    ARUMANAYAGAM P
    J Trop Med Hyg; 1965 May; 68():105-9. PubMed ID: 14287300
    [No Abstract]   [Full Text] [Related]  

  • 28. [100 years of studying poliomyelitis virus and nonpoliomyelitis enteroviruses].
    Lashkevich VA
    Vopr Virusol; 2008; 53(4):41-4. PubMed ID: 18756817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative testing experience with consecutive lots of oral poliomyelitis vaccine.
    CABASSO VJ; JERVIS GA; MOYER AW; ROCA-GARCIA M; ORSI EV; COX HR
    Br Med J; 1960 Feb; 1(5170):373-87. PubMed ID: 13806667
    [No Abstract]   [Full Text] [Related]  

  • 30. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine.
    MELNICK JL; STINEBAUGH S
    Proc Soc Exp Biol Med; 1962 Apr; 109():965-8. PubMed ID: 14472428
    [No Abstract]   [Full Text] [Related]  

  • 31. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin I LSc 2 ab) by oral administration. II. Study of the results of vaccination. Characterization of the virus eliminated by the vaccines].
    Boué A; Drouhet V
    Arch Gesamte Virusforsch; 1966; 18(1):59-71. PubMed ID: 4294187
    [No Abstract]   [Full Text] [Related]  

  • 32. [POLIOMYELITIS-LIKE PARALYTIC DISEASE IN CHILDREN INOCULATED WITH SABIN LIVE VACCINE].
    BARTOSHEVICH EN; TSUKER MB; LESHCHINSKAIA EV; SOKOLOVA IS; MARTYNENKO IN; ANDREEVA LS; ASHMARINA EE
    Vestn Akad Med Nauk SSSR; 1963; 18():16-21. PubMed ID: 14064651
    [No Abstract]   [Full Text] [Related]  

  • 33. The PRESENT status of oral live poliovirus vaccines.
    Can Med Assoc J; 1960 Sep; 83(11):606-7. PubMed ID: 13856943
    [No Abstract]   [Full Text] [Related]  

  • 34. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J; Levenbook I
    Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [SHOULD ATTENUATED POLIOMYELITIS VIRUS VACCINE BE ADMINISTERED TO SUBJECTS PREVIOUSLY VACCINATED BY KILLED VIRUS?].
    GILLET P; THIRY L
    Acta Paediatr Belg; 1964; 18():145-61. PubMed ID: 14166431
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of poliovirus vaccine live, oral (Sabin), trivalent, in metropolitan Toronto, 1962.
    BOYD AR; MOSLEY W
    Can J Public Health; 1962 Aug; 53():326-9. PubMed ID: 13872138
    [No Abstract]   [Full Text] [Related]  

  • 37. Mass immunization with Sabin and Cox oral poliomyelitis vaccines. Experience in Monroe and Tompkins Counties, New York, 1960.
    RATHBUN ML; BROAD RH; FONT W; MILHAM S; AMES WR
    N Y State J Med; 1962 Jun; 62():1767-75. PubMed ID: 14490520
    [No Abstract]   [Full Text] [Related]  

  • 38. [Certain experiences with the preparation of inactivated poliomyelitis vaccine in Czechoslovakia. I. Glass, rubber, stainless material].
    SLONIM D; MICHL J; MARES I; CINNEROVA O; DREVO M
    Cesk Epidemiol Mikrobiol Imunol; 1959 Sep; 8():289-98. PubMed ID: 13831710
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the new control methods for oral poliomyelitis vaccine.
    Grachev VP; Karganova GG; Rumyantsev AA; Ivanova OE; Eremeeva TP; Drozdov SG
    Dev Biol (Basel); 2001; 105():211-7. PubMed ID: 11763330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Booster effect of Sabin poliomyelitis vaccine.
    Teplý V; Srámová H; Svandová E
    Bull World Health Organ; 1976; 54(6):681-4. PubMed ID: 1088514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.